Crossmark

Prediction and clinical implications of HBV reactivation in lymphoma patients with resolved HBV infection: focus on anti-HBs and anti-HBc antibody titers

Crossref DOI link: https://doi.org/10.1007/s12072-019-09966-z

Published Online: 2019-07-09

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nishida, Tsutomu https://orcid.org/0000-0003-4037-9003
Matsubara, Tokuhiro

Yakushijin, Takayuki

Inada, Masami
License Information

Text and Data Mining valid from 2019-07-01

Version of Record valid from 2019-07-01
More Information

Article History

Received: 4 May 2019

Accepted: 25 June 2019

First Online: 9 July 2019

Compliance with ethical standards

:

: Tsutomu Nishida, Tokuhiro Matsubara, Takayuki Yakushijin and Masami Inada declare no conflict of interest. The authors alone are responsible for the content and writing of this paper.

Document is current

Any future updates will be listed below